Amplifon (AMFPF) versus Its Peers Critical Contrast

Amplifon (OTCMKTS:AMFPF) is one of 233 public companies in the “Healthcare Providers & Services” industry, but how does it compare to its rivals? We will compare Amplifon to similar businesses based on the strength of its valuation, profitability, institutional ownership, dividends, earnings, analyst recommendations and risk.

Profitability

This table compares Amplifon and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Amplifon	3.12%	14.94%	4.42%
Amplifon Competitors	-8.06%	-136.95%	-1.64%

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Amplifon and its rivals, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Amplifon	1	1	2	0	2.25
Amplifon Competitors	1871	7745	13372	828	2.55

As a group, “Healthcare Providers & Services” companies have a potential upside of 14.04%. Given Amplifon’s rivals stronger consensus rating and higher possible upside, analysts plainly believe Amplifon has less favorable growth aspects than its rivals.

Volatility and Risk

Amplifon has a beta of 0.67, meaning that its share price is 33% less volatile than the S&P 500. Comparatively, Amplifon’s rivals have a beta of 0.98, meaning that their average share price is 2% less volatile than the S&P 500.

Valuation & Earnings

This table compares Amplifon and its rivals gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Amplifon	$2.71 billion	$103.33 million	36.88
Amplifon Competitors	$21.12 billion	$301.67 million	-1.55

Amplifon’s rivals have higher revenue and earnings than Amplifon. Amplifon is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Institutional and Insider Ownership

56.7% of shares of all “Healthcare Providers & Services” companies are held by institutional investors. 15.0% of shares of all “Healthcare Providers & Services” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Amplifon rivals beat Amplifon on 9 of the 13 factors compared.

Amplifon Company Profile

Amplifon is an Italian hearing-care company founded in Milan in 1950. It provides hearing solutions through a network of retail locations and other customer-service channels. The company offers hearing assessments, advice on hearing aids, device fitting and personalization, and ongoing support. Its products and services also include hearing-aid accessories and maintenance. Amplifon serves customers across Europe, the Americas and the Asia-Pacific region. Its operations include the Amplifon brand and other local hearing-care businesses.